NEW YORK (GenomeWeb News) — Cepheid today said it has acquired PCR diagnostics company Sangtec Molecular Diagnostics from Altana Pharma for around $27 million in cash.   
Cepheid CEO John Bishop said the acquisition gives the company a “relatively complete line of products for managing infections of immunocompromised patients.”  
 
Bishop said the firm will also provide Cepheid with an established reagent-manufacturing base in Europe.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.